2014 Annual Meeting | 2HC.014 - Child Neurology II

Date Sunday 04/27/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be able to incorporate newer diagnostic and therapeutic approaches to the management of these categories of neurologic disease occurring in children and adolescents and should be aware of the practice parameters that apply.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:05 PM		Introduction Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��
01:05 PM - 01:50 PM		Drug-Induced Movement Disorders in Children Erika F. Augustine, MD, F�鶹��ýӳ��
01:50 PM - 02:00 PM		Questions and Answers Erika F. Augustine, MD, F�鶹��ýӳ��
02:00 PM - 02:45 PM		Diagnosis and Treatment of ADEM and MS in Children Brenda L. Banwell, MD, F�鶹��ýӳ��
02:45 PM - 02:55 PM		Questions and Answers Brenda L. Banwell, MD, F�鶹��ýӳ��
02:55 PM - 03:10 PM		Break
03:10 PM - 03:55 PM		Neurologic Complications of Brain Tumors and Childhood Cancer Nicole Ullrich, MD, PhD, MMSci, F�鶹��ýӳ��
03:55 PM - 04:05 PM		Questions and Answers Nicole Ullrich, MD, PhD, MMSci, F�鶹��ýӳ��
04:05 PM - 04:50 PM		Headaches in Children and Adolescents Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��
04:50 PM - 05:00 PM		Questions and Answers Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��

Faculty Disclosures
Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Brenda L. Banwell, MD, F�鶹��ýӳ��	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Erika F. Augustine, MD, F�鶹��ýӳ��	The institution of Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Augustine has received research support from NIH. The institution of Dr. Augustine has received research support from Beyond Batten Disease Foundation. Dr. Augustine has received publishing royalties from a publication relating to health care. Dr. Augustine has a non-compensated relationship as a Member, Board of Directors with American Brain Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Augustine has a non-compensated relationship as a Scientific Advisor with ARIA that is relevant to �鶹��ýӳ�� interests or activities.
Nicole Ullrich, MD, PhD, MMSci, F�鶹��ýӳ��	The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��	Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Mack has received publishing royalties from a publication relating to health care. Dr. Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Justice, DVIC.